Congratulations to UM member Dr Sabrina H Rossi, who received the Best Abstract Presentation Award in her session at the European Association of Urology (EAU) Congress 2026 in London. Sabrina presented research examining the prevalence of kidney cancer in people attending lung cancer screening and combined lung and abdominal screening. As targeted lung cancer screening continues to roll out across the UK, understanding how many kidney cancers are detected in this high-risk

A blog from Dr Chiara Re, Research Fellow at University of Cambridge. Supporting better decisions after kidney cancer surgery For most patients treated for kidney cancer, the journey does not end with surgery. Up to 30% will experience recurrence within five years, making a transition to follow-up care essential but often challenging. Guidelines recommend tailoring surveillance to a patient’s recurrence risk, but implementation varies between centres. Patients report little

A blog from UMVI member Dr Mouhamad Ismail, who recently attended the 2026 International Kidney Cancer Symposium (IKCS) in Paris, from 16-18 April. At the Symposium, Dr Ismail presented a poster on the International Neoadjuvant Kidney Cancer Consortium (INKCC), using data from the UMVI’s ARTIST project. Attending the 2026 International Kidney Cancer Symposium (IKCS) was an invaluable opportunity to learn from leaders in the field of kidney cancer and to engage with the latest

Led by UM-lead Professor Grant Stewart, the National Institute for Health and Care Excellence (NICE) have published the first clinical guideline for kidney cancer, providing a comprehensive overview of the diagnosis, treatment, and care of adults with suspected or confirmed renal cell carcinoma. Professor Grant Stewart was clinical lead for developing the new guidelines - photo CUH Kidney cancer is the sixth most common adult cancer in the UK, and early detection is challengi

This third blog in our series on International Neoadjuvant Kidney Cancer Consortium (INKCC) , outlines the first guidelines published by...

In a European Urology Oncology paper, UM member Sabrina H Rossi and colleagues use data from the Yorkshire Kidney Screening Trial (YKST)...

In this second part of our blog series on the work of the International Neoadjuvant Kidney Cancer Consortium (INKCC) we consider how...

As the landscape of kidney cancer treatment evolves, the need for innovative and joined-up strategies has never been more critical. ...

A Cambridge-led clinical trial has revealed how a short course of targeted therapy prior to surgery can influence the biology of prostate...

In a systematic review of follow-up guidelines for 16 solid cancers , published in BMJ Oncology, researchers have made a call ‘for an...

Last week, during Kidney Cancer Awareness Week (3–7 February 2025), the Cancer Research UK Cambridge Centre shone a light on research by...

Combining screening for lung and kidney cancers is feasible and acceptable to participants.

Many congratulations to Tom Mitchell who has been appointed as the Krishnan-Ang Distinguished Group Leader in the Urological Malignancies...

On 12 September, we held our second bi-annual Urological Malignancies Symposium. To celebrate the launch of the Urological Malignancies...

Risk-stratified screening for kidney cancer may improve early detection by targeting high-risk individuals

UM Programme co-lead Professor Grant Stewart makes the case in the Lancet this week for an evidence-based strategy for streamlining...

In recognition of his 'sizeable contributions to research', Urological Malignancies Programme co-lead Dr Brent O'Carrigan has been...

Urological Malignancies Programme co-lead Dr Brent O'Carrigan has been selected for ESMO's prestigious Leaders Generation Programme for...

Urological Malignancies Programme co-lead Professor Grant Stewart contributed to a feature on the future of technology in medicine in...

From 1st February 2023, Dr Brent O'Carrigan joins Professor Grant Stewart as co-lead for the UM Programme. Brent replaces Dr Sarah Welsh,...